Cat. No JK837002_5_MG
J&K Chemical

Product Information

Product Name
Panobinostat, 98%
Brand Name
J&K
Product Number
837002
CAS
404950-80-7
Molecular Formula
C21H23N3O2
Molecular Weight
349.43
Certificate of Analysis (COA)​
COA not found

General Information

Synonyms
  • LBH 589
  • €-N-Hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylamide
PubChem CID
6918837
IUPAC Name
(E)-N-hydroxy-3-4-2-(2-methyl-1H-indol-3-yl)ethylaminomethylphenylprop-2-enamide
InChI Key
FPOHNWQLNRZRFC-ZHACJKMWSA-N
SMILES
CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO

Properties

Melting Point
>115
Boiling Point
608.15
n20D
1.6800

Safety Information

GHS Symbols
Hazard Symbol
Signal Word
Danger
Hazard Statement
H302
H315
H319
H332
H335
Precautionary Statement
P270
P330
P501
P280
P321
P261
P271
P319
P405
P301+P317
P302+P352
P332+P317
P362+P364
P264+P265
P305+P351+P338
P337+P317
P304+P340
P403+P233
Storage Condition
Freezer -20℃

References Data Source From Pubchem

CITED2 is a druggable epigenetic switch coupling neuronal maturation to regenerative decline

Publication Name: EMBO Molecular Medicine
Publication Date: 2026-02-23
DOI: 10.1038/s44321-026-00385-w

Theranostic and Radionuclide-based Treatment Approaches for Radioiodine-refractory Thyroid Cancer: From Biology to Clinical Application

Publication Name: Molecular Imaging and Biology
Publication Date: 2026-02-18
DOI: 10.1007/s11307-026-02082-z

CAR-T cell immunotherapy in rhabdomyosarcoma

Publication Name: Journal of Translational Medicine
Publication Date: 2026-02-18
DOI: 10.1186/s12967-026-07773-3

Anti-myeloma activity of the CXCR4 antagonist WZ811

Publication Name: Journal of molecular medicine (Berlin, Germany)
Publication Date: 2026-02-17
DOI: 10.1007/s00109-026-02650-4

Panobinostat, 98%

Just added to your wishlist:
My Wishlist
You've just added this product to the cart:
Go to cart page